Epizyme Appoints Oncology Industry Leader Michael Giordano, MD, to its Board of Directors

...directors . Dr. Giordano brings to the... CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced ...
Read Full Article